CA Patent

CA3058678A1 — Gamete-secreted growth factors

Assigned to Anlagen Pty Ltd · Expires 2018-08-09 · 8y expired

What this patent protects

The present invention relates to diagnostic markers of fertility, reproductive dysfunction and infertility management. In particular, the invention relates a method for predicting the fertility potential of a subject, the method comprising determining the level of one or more of …

USPTO Abstract

The present invention relates to diagnostic markers of fertility, reproductive dysfunction and infertility management. In particular, the invention relates a method for predicting the fertility potential of a subject, the method comprising determining the level of one or more of GDF9, BMP15 and/or cumulin in the subject.

Drugs covered by this patent

Patent Metadata

Patent number
CA3058678A1
Jurisdiction
CA
Classification
Expires
2018-08-09
Drug substance claim
No
Drug product claim
No
Assignee
Anlagen Pty Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.